Delivering Revolutionary Cell/Gene Therapies to the Underserved, Creating More Accessibility
By David Jensen,
The California Stem Cell Report
| 04. 24. 2023
What good is a “miraculous” cure or a revolutionary therapy -- which is the goal of a $12 billion state of California enterprise -- if it is not accessible to patients?
That’s a question implicitly posed by a former member of the governing board of that enterprise, the California Institute for Regenerative Medicine (CIRM), more commonly known as the stem cell agency. And he had an answer to the question and a suggestion for the state program.
The remarks come from Jeff Sheehy, who served on the board for 16 years beginning in 2004, the year CIRM was created. He sent the California Stem Cell Report a note after the publication of an article about CIRM’s $80 million effort to create a public-private manufacturing network to overcome obstacles to the production of stem cell and related therapies.
Sheehy spoke to the lack of availability of advanced medical care in underserved areas of California, many of which are rural and remote from the centers where cell and genetic treatments can be done. He proposed that CIRM develop a “capacity...
Related Articles
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Carey Gillan, UnSpun | 03.18.2024
A Mexican standoff with the United States turned into a Mexican smack-down this month with the release of Mexico’s formal rebuttal to US efforts to overturn limits Mexico has ordered on the use of genetically modified (GM) corn and the...
By Hilary Brueck, Business Insider | 03.23.2024
"OpenAI Co-Founder & CEO Sam Altman speaks onstage during TechCrunch Disrupt San Francisco 2019 at Moscone Convention Center on October 03, 2019 in San Francisco, California (Photo by Steve Jennings/Getty Images for TechCrunch)" by TechCrunch is licensed under CC by...